Simplex Trading’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Simplex Trading’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-625	Closed	-$3K	–	11061
2022 Q2	$3K	Sell	625 -250	-29%	-$6.26K	﹤0.01%	9224
2022 Q1	$31K	Sell	875 -123	-12%	-$4.42K	﹤0.01%	7743
2021 Q4	$35K	Buy	998 +365	+58%	+$19.2K	﹤0.01%	7711
2021 Q3	$55K	Sell	633 -4	-0.6%	-$284	﹤0.01%	7415
2021 Q2	$55K	Buy	637 +636	+63,600%	+$60.5K	﹤0.01%	7542
2021 Q1	$11K	Hold	1	–	–	﹤0.01%	7856
2020 Q4	$2K	Buy	+1	New	+$37	﹤0.01%	8026
2020 Q3	–	Hold	0	–	-$1K	–	8676
2020 Q2	–	Hold	0	–	–	–	7430
2020 Q1	–	Sell	-2	Closed	-$15K	–	8407
2019 Q4	$15K	Sell	2 -7	-78%	-$653	﹤0.01%	6163
2019 Q3	$93K	Buy	9 +4	+80%	+$866	﹤0.01%	4400
2019 Q2	$141K	Buy	5 +3	+150%	+$1.06K	﹤0.01%	3838
2019 Q1	$95K	Buy	+2	New	+$777	﹤0.01%	4385
2018 Q4	–	Hold	0	–	-$4K	–	7959
2018 Q3	–	Hold	0	–	–	–	6881
2018 Q2	–	Hold	0	–	–	–	6830
2018 Q1	–	Sell	-2	Closed	-$3K	–	6998
2017 Q4	$3K	Buy	+2	New	+$416	﹤0.01%	5013

Other funds holding CSCI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Simplex Trading's CSCI Position: Q3 2022 in Review

Simplex Trading sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2022, closing a stake of 328 shares — an estimated $6K sold.

Simplex Trading first reported a position in CSCI in Q2 2016 and held it in 13 quarters. The position peaked at $62K in Q3 2021. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

Simplex Trading reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Simplex Trading sold 328 COSCIENS Biopharma Inc. Common Stock shares in Q3 2022, an estimated $6K.
Simplex Trading first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2016 and held it in 13 quarters.
Simplex Trading's COSCIENS Biopharma Inc. Common Stock position peaked at $62K in Q3 2021.
12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.